1 / 1

Tasimelteon - CAS 609799-22-6

tTasimelteon (trade name Hetlioz) is a drug approved by the FDA solely for the treatment of non-24-hour sleepu2013wake disorder (often designated as N24HSWD) in totally blind adults. It is a selective agonist for the melatonin receptors MT1 and MT2 in the suprachiasmatic nucleus of the brain, similar to other members of the melatonin receptor agonist class of which ramelteon (2005) and agomelatine (2009) were the first approved.

BOCSCI_4516_
Download Presentation

Tasimelteon - CAS 609799-22-6

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tasimelteon - CAS 609799-22-6 Website: https://www.bocsci.com/tasimelteon-cas-609799-22-6-item-72984.html Address: 45-16 Ramsey Road, Shirley, NY 11967, USA

More Related